表紙
市場調査レポート

脳内出血:世界の治験レビュー

Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 308257
出版日 ページ情報 英文 88 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
脳内出血:世界の治験レビュー Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014
出版日: 2014年07月14日 ページ情報: 英文 88 Pages
概要

当レポートでは、脳内出血に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、地域フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 脳内出血
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:中枢神経系の治験件数に対する脳内出血の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7(新興7ヶ国)諸国での治験件数:中枢神経系の治験件数に対する脳内出血の治験件数比率

E7(新興7ヶ国)諸国での治験件数:フェーズ(相)別

E7(新興7ヶ国)諸国での治験件数:進捗状況別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

未達成の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

治験のプロファイル

  • 代表的企業の治験の概要
    • Novo A/S
    • The Medicines Company
    • Pfizer Inc.
    • Octapharma AG
    • GlaxoSmithKline plc
    • AstraZeneca PLC
  • 代表的な研究機関・病院の治験の概要
    • Johns Hopkins University
    • Beth Israel Deaconess Medical Center
    • University of Minnesota
    • Sunnybrook Health Sciences Centre
    • Thomas Jefferson University
    • University of California, Los Angeles
    • University of Erlangen-Nurnberg
    • The George Institute for Global Health
    • University of Oulu
    • University of Heidelberg

5つの代表的な治験のプロファイル

付録

図表一覧

目次
Product Code: GDHC2237CTIDB

GlobalData's clinical trial report, "Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014" provides data on the Intracerebral Hemorrhage clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intracerebral Hemorrhage. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Intracerebral Hemorrhage. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Intracerebral Hemorrhage
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Intracerebral Hemorrhage to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Intracerebral Hemorrhage to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Intracerebral Hemorrhage
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Intracerebral Hemorrhage Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novo A/S
      • Clinical Trial Overview of Novo A/S
      • The Medicines Company
      • Clinical Trial Overview of The Medicines Company
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Octapharma AG
      • Clinical Trial Overview of Octapharma AG
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
    • Clinical Trial Overview of Top Institutes / Government
      • Johns Hopkins University
      • Clinical Trial Overview of Johns Hopkins University
      • Beth Israel Deaconess Medical Center
      • Clinical Trial Overview of Beth Israel Deaconess Medical Center
      • University of Minnesota
      • Clinical Trial Overview of University of Minnesota
      • Sunnybrook Health Sciences Centre
      • Clinical Trial Overview of Sunnybrook Health Sciences Centre
      • Thomas Jefferson University
      • Clinical Trial Overview of Thomas Jefferson University
      • University of California, Los Angeles
      • Clinical Trial Overview of University of California, Los Angeles
      • University of Erlangen-Nurnberg
      • Clinical Trial Overview of University of Erlangen-Nurnberg
      • The George Institute for Global Health
      • Clinical Trial Overview of The George Institute for Global Health
      • University of Oulu
      • Clinical Trial Overview of University of Oulu
      • University of Heidelberg
      • Clinical Trial Overview of University of Heidelberg
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials by Region, 2014*
  • Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Intracerebral Hemorrhage to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Intracerebral Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Intracerebral Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Intracerebral Hemorrhage to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Intracerebral Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Intracerebral Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Intracerebral Hemorrhage Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Intracerebral Hemorrhage Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Intracerebral Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medicines Company, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Erlangen-Nurnberg, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by The George Institute for Global Health, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oulu, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2014*

List of Figures

  • Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Intracerebral Hemorrhage to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Intracerebral Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Intracerebral Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Intracerebral Hemorrhage to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Intracerebral Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Intracerebral Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Intracerebral Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top